Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Science (New York, N.Y.) | Oct 2, 1998

http://www.ncbi.nlm.nih.gov/pubmed/9756471

To better understand the dynamics of hepatitis C virus and the antiviral effect of interferon-alpha-2b (IFN), viral decline in 23 patients during therapy was analyzed with a mathematical model. The analysis indicates that the major initial effect of IFN is to block virion production or release, with blocking efficacies of 81, 95, and 96% for daily doses of 5, 10, and 15 million international units, respectively. The estimated virion half-life (t1/2) was, on average, 2.7 hours, with pretreatment production and clearance of 10(12) virions per day. The estimated infected cell death rate exhibited large interpatient variation (corresponding t1/2 = 1.7 to 70 days), was inversely correlated with baseline viral load, and was positively correlated with alanine aminotransferase levels. Fast death rates were predictive of virus being undetectable by polymerase chain reaction at 3 months. These findings show that infection with hepatitis C virus is highly dynamic and that early monitoring of viral load can help guide therapy.

Pubmed ID: 9756471 RIS Download

Mesh terms: Alanine Transaminase | Antiviral Agents | Cell Death | Dose-Response Relationship, Drug | Half-Life | Hepacivirus | Hepatitis C | Humans | Interferon-alpha | Kinetics | Models, Biological | RNA, Viral | Recombinant Proteins | Regression Analysis | Viral Load | Viremia | Virion | Virus Replication

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.